About ImmunoMark Summit
We exist to accelerate the translation of immuno-oncology science and biomarker innovation from discovery into clinical outcomes — by building the world's most focused community of IO and precision medicine leaders.
Accelerating the translation of IO science into measurable clinical outcomes
ImmunoMark Summit was founded on a simple but urgent conviction: the gap between what we know in the lab and what reaches patients is too wide, and too slow to close. The oncology community generates extraordinary science — but the infrastructure for translating that science into validated biomarker strategies, commercial frameworks, and clinical practice has lagged behind.
We built ImmunoMark Summit to close that gap — not through academic symposia or vendor-driven conferences, but through a rigorously curated, senior-audience platform that forces the right conversations between the right people at the right time. Every element of our programme — from speaker selection to stream design to networking architecture — is engineered to accelerate translation.
Our vision is a world where every cancer patient benefits from a biomarker-informed treatment strategy. That requires a global community of oncology leaders — scientists, clinicians, regulators, and industry executives — who think, collaborate, and move together. ImmunoMark Summit is where that community meets.
The ImmunoMark Story
The Concept
Convolign Business Consulting identified a critical gap in the conference landscape — no event was dedicated exclusively to the intersection of immuno-oncology and biomarker science.
London 2026 Announced
Speaker recruitment, sponsor outreach and programme curation began with strong early interest from the European biopharma community.
London 2026 — Delivered
400+ delegates, 36 speakers, 7 sponsors and two parallel streams with a Gala Dinner. Post-event surveys showed strong recommendation scores.
Boston 2026 — Coming Next
Building on the success of London, ImmunoMark Summit crosses the Atlantic to Boston — the world's most concentrated biotech and oncology hub.
View Boston 2026 →The People Behind ImmunoMark
ImmunoMark Summit is organised and delivered by the team at Convolign Business Consulting LLP. Placeholder cards below — client to update with real names, photos, and bios.
What Makes Us Different
The only conference series dedicated to the intersection of Immuno-Oncology and Biomarker science.
Dual-Stream Format
Two fully independent parallel tracks - Immuno-Oncology and Biomarkers & CDx - for in-depth, targeted learning.
Senior-Level Audience
45-50% of attendees are C-suite, VPs, and Directors from pharma, biotech, and diagnostics companies globally.
Facilitated Networking
Structured 1:1 meetings, panel discussions, and a Gala Dinner designed for meaningful strategic connections.
Two Global Biotech Hubs
London and Boston - the world's leading centres for oncology drug development and biotech innovation.
Translational + Commercial
Programs bridge bench science with regulatory, clinical, and commercialization strategy - relevant to all stakeholders.
Proven Speaker Roster
Experts from AstraZeneca, Roche, Merck, J&J, Novartis, GSK, Oxford, and more - setting the scientific standard.
Convolign
Business Consulting LLPConvolign Business Consulting LLP is a specialist life sciences consultancy focused on conference production, market intelligence, and strategic advisory services for the biopharma, diagnostics, and oncology sectors. Based across Boston and London, Convolign combines deep scientific understanding with commercial expertise to create high-impact platforms for the global life sciences community.
ImmunoMark Summit is Convolign's flagship conference series — designed and delivered in-house from concept through to on-site execution. Every element, from scientific programme curation to delegate experience design, is produced by the Convolign team with a commitment to quality, rigour, and genuine value for every attendee.
Ready to Join Us?
Register For Boston 2026
Two passes from $299. Join 400+ senior oncology professionals in Boston this October.
Register NowExplore Boston 2026 Sponsorship
8 packages from Headline to bespoke. Position your brand at the centre of precision oncology.
View PackagesRead the Blog
Deep dives on IO, biomarkers, CDx, and regulatory science from our editorial team.
Visit the Blog